Imexpharm Corp (IMP) — Cash Flow Reinvestment Rate
Imexpharm Corp (IMP) has a Cash Flow Reinvestment Rate of 0.08x as of March 2026, reinvesting ₫7.79 Billion (capex ₫7.79 Billion ) from operating cash flow of ₫103.49 Billion. Check IMP operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Imexpharm Corp Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Imexpharm Corp across 6 annual periods. Explore IMP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Imexpharm Corp (2019–2025)
Year-by-year capital reinvestment analysis for Imexpharm Corp. For live market cap and broader valuation context, see market value of Imexpharm Corp.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | ₫26.88 Billion | ₫54.17 Billion | ₫26.88 Billion | ▼ -52.1% |
| 2024 | 1.04x | ₫223.97 Billion | ₫216.27 Billion | ₫96.77 Billion | ▲ +31.3% |
| 2022 | 0.79x | ₫298.66 Billion | ₫378.60 Billion | ₫99.35 Billion | ▼ -37.8% |
| 2021 | 1.27x | ₫297.80 Billion | ₫234.88 Billion | ₫52.86 Billion | ▼ -52.6% |
| 2020 | 2.67x | ₫195.62 Billion | ₫73.15 Billion | ₫89.68 Billion | ▲ +9.1% |
| 2019 | 2.45x | ₫163.21 Billion | ₫66.59 Billion | ₫131.12 Billion | — |